15 employees
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
2014
$1.7M
from 1 investors over 1 rounds
Injectsense Inc. raised $1.7M on March 1, 2022
Investors: National Eye Institute (NEI)